Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass.

Harris LA, Kayser BD, Cefalo C, Marini L, Watrous JD, Ding J, Jain M, McDonald JG, Thompson BM, Fabbrini E, Eagon JC, Patterson BW, Mittendorfer B, Mingrone G, Klein S.

Cell Metab. 2019 Sep 24. pii: S1550-4131(19)30503-0. doi: 10.1016/j.cmet.2019.09.002. [Epub ahead of print]

PMID:
31588013
2.

Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device.

Casella-Mariolo J, Castagneto-Gissey L, Angelini G, Zoli A, Marini P, Bornstein SR, Pournaras DJ, Rubino F, le Roux CW, Mingrone G, Casella G.

EBioMedicine. 2019 Aug;46:452-462. doi: 10.1016/j.ebiom.2019.07.069. Epub 2019 Aug 7.

3.

A new sensitive and accurate model to predict moderate to severe obstructive sleep apnea in patients with obesity.

Ahlin S, Manco M, Panunzi S, Verrastro O, Giannetti G, Prete A, Guidone C, Berardino ADM, Viglietta L, Ferravante A, Mingrone G, Mormile F, Capristo E.

Medicine (Baltimore). 2019 Aug;98(32):e16687. doi: 10.1097/MD.0000000000016687.

4.

Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity.

Ahlin S, Cefalù C, Bondia-Pons I, Capristo E, Marini L, Gastaldelli A, Mingrone G, Nolan JJ.

Br J Surg. 2019 Aug;106(9):1178-1186. doi: 10.1002/bjs.11208. Epub 2019 Jun 19.

5.

Treatment of persistent or recurrent type 2 diabetes after metabolic surgery.

Mingrone G.

Lancet Diabetes Endocrinol. 2019 Jul;7(7):504-505. doi: 10.1016/S2213-8587(19)30195-0. Epub 2019 Jun 4. No abstract available.

PMID:
31174992
6.

Effect of single anastomosis duodenal-ileal bypass with sleeve gastrectomy on glucose tolerance test: comparison with other bariatric procedures.

Sessa L, Guidone C, Gallucci P, Capristo E, Mingrone G, Raffaelli M.

Surg Obes Relat Dis. 2019 Jul;15(7):1091-1097. doi: 10.1016/j.soard.2019.04.013. Epub 2019 Apr 19.

PMID:
31130403
7.

Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetologia. 2019 May;62(5):873. doi: 10.1007/s00125-019-4845-x.

PMID:
30899969
8.

Correction to: One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort.

Manco M, Mari A, Petrie J, Mingrone G, Balkau B; EGIR-RISC study group.

Diabetologia. 2019 May;62(5):874. doi: 10.1007/s00125-019-4846-9.

PMID:
30899968
9.

Corrigendum to "Intensive lifestyle modifications with or without liraglutide 3mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study" [Diabetes Metab. 44 (2018) 235-242].

Capristo E, Panunzi S, De Gaetano A, Raffaelli M, Guidone C, Iaconelli A, L'Abbate L, Birkenfeld AL, Bellantone R, Bornstein S, Mingrone G.

Diabetes Metab. 2019 Mar 8. pii: S1262-3636(19)30031-X. doi: 10.1016/j.diabet.2019.02.004. [Epub ahead of print] No abstract available.

PMID:
30857948
10.

Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells.

Grande R, Dovizio M, Marcone S, Szklanna PB, Bruno A, Ebhardt HA, Cassidy H, Ní Áinle F, Caprodossi A, Lanuti P, Marchisio M, Mingrone G, Maguire PB, Patrignani P.

Front Pharmacol. 2019 Jan 22;10:7. doi: 10.3389/fphar.2019.00007. eCollection 2019.

11.

One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort.

Manco M, Mari A, Petrie J, Mingrone G, Balkau B; EGIR-RISC study group.

Diabetologia. 2019 Mar;62(3):544-548. doi: 10.1007/s00125-018-4798-5. Epub 2018 Dec 29. No abstract available. Erratum in: Diabetologia. 2019 May;62(5):874.

12.

Alexithymia affects patients with hidradenitis suppurativa.

Chiricozzi A, Giovanardi G, Caro DRC, Iannone M, Garcovich S, Dini V, De Simone C, Franceschini C, Oranges T, Mingrone G, Capristo E, Di Raimondo C, Bianchi L, Peris K.

Eur J Dermatol. 2018 Aug 1;28(4):482-487. doi: 10.1684/ejd.2018.3368.

PMID:
30325328
13.

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.

PMID:
30291106
14.

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5. Erratum in: Diabetologia. 2019 May;62(5):873.

PMID:
30288571
15.

Response to Letter to the Editor: "Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial".

Capristo E, Panunzi S, De Gaetano A, Spuntarelli V, Bellantone R, Giustacchini P, Birkenfeld AL, Amiel S, Bornstein SR, Raffaelli M, Mingrone G.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):732-733. doi: 10.1210/jc.2018-01813. No abstract available.

PMID:
30285256
16.

Metabolic surgery improves insulin resistance through the reduction of gut-secreted heat shock proteins.

Angelini G, Salinari S, Bertuzzi A, Iaconelli A, Mingrone G.

Commun Biol. 2018 Jun 13;1:69. doi: 10.1038/s42003-018-0069-8. eCollection 2018.

17.

Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance.

Debédat J, Sokolovska N, Coupaye M, Panunzi S, Chakaroun R, Genser L, de Turenne G, Bouillot JL, Poitou C, Oppert JM, Blüher M, Stumvoll M, Mingrone G, Ledoux S, Zucker JD, Clément K, Aron-Wisnewsky J.

Diabetes Care. 2018 Oct;41(10):2086-2095. doi: 10.2337/dc18-0567. Epub 2018 Aug 6.

PMID:
30082327
18.

Cognitive Function in Individuals with Normal Weight Obesity: Results from the Third National Health and Nutrition Examination Survey (NHANES III).

Malandrino N, Capristo E, Taveira TH, Mingrone G, Wu WC.

J Alzheimers Dis. 2018;65(1):125-135. doi: 10.3233/JAD-180264.

PMID:
30010127
19.

The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery.

von Loeffelholz C, Gissey LC, Schumann T, Henke C, Kurzbach A, Struck J, Bergmann A, Hanefeld M, Schatz U, Bornstein SR, Casella G, Mingrone G, Birkenfeld AL.

Int J Obes (Lond). 2018 Dec;42(12):2057-2061. doi: 10.1038/s41366-018-0084-3. Epub 2018 May 24.

PMID:
29795470
20.

Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial.

Capristo E, Panunzi S, De Gaetano A, Spuntarelli V, Bellantone R, Giustacchini P, Birkenfeld AL, Amiel S, Bornstein SR, Raffaelli M, Mingrone G.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2136-2146. doi: 10.1210/jc.2017-01695.

PMID:
29590421
21.

Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.

Castagneto Gissey L, Casella Mariolo J, Mingrone G.

Peptides. 2018 Feb;100:114-122. doi: 10.1016/j.peptides.2017.12.010. Review.

PMID:
29412812
22.

Intensive lifestyle modifications with or without liraglutide 3mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study.

Capristo E, Panunzi S, De Gaetano A, Raffaelli M, Guidone C, Iaconelli A, L'Abbate L, Birkenfeld AL, Bellantone R, Bornstein SR, Mingrone G.

Diabetes Metab. 2018 Jun;44(3):235-242. doi: 10.1016/j.diabet.2017.12.007. Epub 2017 Dec 29. Erratum in: Diabetes Metab. 2019 Mar 8;:.

PMID:
29398254
23.

Optimisation of follow-up after metabolic surgery.

Mingrone G, Bornstein S, Le Roux CW.

Lancet Diabetes Endocrinol. 2018 Jun;6(6):487-499. doi: 10.1016/S2213-8587(17)30434-5. Epub 2018 Jan 29. Review.

PMID:
29396249
24.

The relationship between bone turnover and insulin sensitivity and secretion: Cross-sectional and prospective data from the RISC cohort study.

Frost M, Balkau B, Hatunic M, Konrad T, Mingrone G, Højlund K.

Bone. 2018 Mar;108:98-105. doi: 10.1016/j.bone.2017.12.029. Epub 2018 Jan 3.

25.

Correlation Between Metabolic Syndrome, Periodontitis and Reactive Oxygen Species Production. A Pilot Study.

Patini R, Gallenzi P, Spagnuolo G, Cordaro M, Cantiani M, Amalfitano A, Arcovito A, Callà C, Mingrone G, Nocca G.

Open Dent J. 2017 Dec 12;11:621-627. doi: 10.2174/1874210601711010621. eCollection 2017.

26.

Lipidomic Changes in Skeletal Muscle in Patients after Biliopancreatic Diversion.

Mehnert CS, Graessler J, Kamvissi-Lorenz V, Castagneto Gissey L, Casella Mariolo JR, Casella G, Mingrone G, Bornstein SR.

Horm Metab Res. 2017 Nov;49(11):880-885. doi: 10.1055/s-0043-120065. Epub 2017 Oct 24.

PMID:
29065430
27.

Downregulation of Insulin Sensitivity After Oral Glucose Administration: Evidence for the Anti-Incretin Effect.

Salinari S, Mingrone G, Bertuzzi A, Previti E, Capristo E, Rubino F.

Diabetes. 2017 Nov;66(11):2756-2763. doi: 10.2337/db17-0234. Epub 2017 Aug 29.

28.

Glycemic control after metabolic surgery: a Granger causality and graph analysis.

Previti E, Salinari S, Bertuzzi A, Capristo E, Bornstein S, Mingrone G.

Am J Physiol Endocrinol Metab. 2017 Nov 1;313(5):E622-E630. doi: 10.1152/ajpendo.00042.2017. Epub 2017 Jul 11.

29.

Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort.

Manco M, Nolfe G, Pataky Z, Monti L, Porcellati F, Gabriel R, Mitrakou A, Mingrone G.

Metabolism. 2017 May;70:42-50. doi: 10.1016/j.metabol.2017.02.007. Epub 2017 Feb 14.

PMID:
28403944
30.

Response to Comment on Gastaldelli et al. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass. Diabetes Care 2016;39:1925-1931.

Gastaldelli A, Rubino F, Mingrone G.

Diabetes Care. 2017 Apr;40(4):e50. doi: 10.2337/dci16-0050. No abstract available.

PMID:
28325806
31.

Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery.

Kamvissi-Lorenz V, Raffaelli M, Bornstein S, Mingrone G.

Curr Atheroscler Rep. 2017 Feb;19(2):9. doi: 10.1007/s11883-017-0642-5. Review.

32.

The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism.

von Loeffelholz C, Lieske S, Neuschäfer-Rube F, Willmes DM, Raschzok N, Sauer IM, König J, Fromm MF, Horn P, Chatzigeorgiou A, Pathe-Neuschäfer-Rube A, Jordan J, Pfeiffer AFH, Mingrone G, Bornstein SR, Stroehle P, Harms C, Wunderlich FT, Helfand SL, Bernier M, de Cabo R, Shulman GI, Chavakis T, Püschel GP, Birkenfeld AL.

Hepatology. 2017 Aug;66(2):616-630. doi: 10.1002/hep.29089. Epub 2017 Jun 26.

33.

Pros and cons of bariatric surgery in adolescents.

Mingrone G.

Lancet Diabetes Endocrinol. 2017 Mar;5(3):152-154. doi: 10.1016/S2213-8587(16)30425-9. Epub 2017 Jan 6. No abstract available.

PMID:
28065735
34.

The influence of preoperative psychological factors on weight loss after bariatric surgery: A preliminary report.

Lai C, Aceto P, Petrucci I, Castelnuovo G, Callari C, Giustacchini P, Sollazzi L, Mingrone G, Bellantone R, Raffaelli M.

J Health Psychol. 2019 Mar;24(4):518-525. doi: 10.1177/1359105316677750. Epub 2016 Nov 16.

PMID:
27852888
35.

A case report of chylous ascites after gastric bypass for morbid obesity.

Capristo E, Spuntarelli V, Treglia G, Arena V, Giordano A, Mingrone G.

Int J Surg Case Rep. 2016;29:133-136. doi: 10.1016/j.ijscr.2016.10.077. Epub 2016 Nov 5.

36.

Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.

Gastaldelli A, Iaconelli A, Gaggini M, Magnone MC, Veneziani A, Rubino F, Mingrone G.

Diabetes Care. 2016 Nov;39(11):1925-1931. Epub 2016 Aug 29.

PMID:
27573937
37.

Changes of insulin sensitivity and secretion after bariatric/metabolic surgery.

Mingrone G, Cummings DE.

Surg Obes Relat Dis. 2016 Jul;12(6):1199-205. doi: 10.1016/j.soard.2016.05.013. Epub 2016 May 13. Review.

PMID:
27568471
38.

Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study.

Rajagopalan H, Cherrington AD, Thompson CC, Kaplan LM, Rubino F, Mingrone G, Becerra P, Rodriguez P, Vignolo P, Caplan J, Rodriguez L, Galvao Neto MP.

Diabetes Care. 2016 Dec;39(12):2254-2261. Epub 2016 Aug 12.

PMID:
27519448
39.

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Daniels MA, Kan C, Willmes DM, Ismail K, Pistrosch F, Hopkins D, Mingrone G, Bornstein SR, Birkenfeld AL.

Pharmacogenomics J. 2016 Oct;16(5):399-410. doi: 10.1038/tpj.2016.54. Epub 2016 Jul 19. Review.

PMID:
27432533
40.

Insulin Resistance, Microbiota, and Fat Distribution Changes by a New Model of Vertical Sleeve Gastrectomy in Obese Rats.

Basso N, Soricelli E, Castagneto-Gissey L, Casella G, Albanese D, Fava F, Donati C, Tuohy K, Angelini G, La Neve F, Severino A, Kamvissi-Lorenz V, Birkenfeld AL, Bornstein S, Manco M, Mingrone G.

Diabetes. 2016 Oct;65(10):2990-3001. doi: 10.2337/db16-0039. Epub 2016 Jul 18.

41.

How to Choose the Best Metabolic Procedure?

Castagneto Gissey L, Casella Mariolo JR, Mingrone G.

Curr Atheroscler Rep. 2016 Jul;18(7):43. doi: 10.1007/s11883-016-0590-5. Review.

PMID:
27229936
42.

Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes.

Schauer PR, Mingrone G, Ikramuddin S, Wolfe B.

Diabetes Care. 2016 Jun;39(6):902-11. doi: 10.2337/dc16-0382.

43.

Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis.

Bertuzzi A, Conte F, Mingrone G, Papa F, Salinari S, Sinisgalli C.

PLoS One. 2016 May 5;11(5):e0154415. doi: 10.1371/journal.pone.0154415. eCollection 2016.

44.

Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery.

Panunzi S, Carlsson L, De Gaetano A, Peltonen M, Rice T, Sjöström L, Mingrone G, Dixon JB.

Diabetes Care. 2016 Jan;39(1):166-74. doi: 10.2337/dc15-0575. Epub 2015 Dec 1.

PMID:
26628418
45.

Changes in insulin sensitivity and secretion after sleeve gastrectomy.

Casella G, Soricelli E, Castagneto-Gissey L, Redler A, Basso N, Mingrone G.

Br J Surg. 2016 Feb;103(3):242-8. doi: 10.1002/bjs.10039. Epub 2015 Nov 9.

PMID:
26550995
46.

Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling.

Severino A, Castagneto-Gissey L, Raffaelli M, Gastaldelli A, Capristo E, Iaconelli A, Guidone C, Callari C, Bellantone R, Mingrone G.

Surg Obes Relat Dis. 2016 Jan;12(1):42-7. doi: 10.1016/j.soard.2015.06.005. Epub 2015 Jun 10.

PMID:
26483070
47.

Leukocyte Activation in Obese Patients: Effect of Bariatric Surgery.

Minervino D, Gumiero D, Nicolazzi MA, Carnicelli A, Fuorlo M, Guidone C, Di Gennaro L, Fattorossi A, Mingrone G, Landolfi R.

Medicine (Baltimore). 2015 Oct;94(40):e1382. doi: 10.1097/MD.0000000000001382.

48.

Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: a meta-analysis of literature studies.

Lupoli R, Di Minno MN, Guidone C, Cefalo C, Capaldo B, Riccardi G, Mingrone G.

Int J Obes (Lond). 2016 Mar;40(3):395-402. doi: 10.1038/ijo.2015.187. Epub 2015 Sep 21. Review.

PMID:
26388348
49.

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F.

Lancet. 2015 Sep 5;386(9997):964-73. doi: 10.1016/S0140-6736(15)00075-6.

PMID:
26369473
50.

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?

Raffaelli M, Sessa L, Mingrone G, Bellantone R.

Diabetes Metab Syndr Obes. 2015 Jun 8;8:255-62. doi: 10.2147/DMSO.S50659. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center